Anika Therapeutics Inc. EBIT Margin

EBIT Margin of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Margin growth rates and interactive chart. Earnings before interest and taxes margin is an indicator of a company's profitability. Calculated as earnings before interest and taxes (EBIT) divided by revenue. It is useful for comparison of companies with different debt levels and tax rates. And EBIT margin gives a clear picture about the underlying profitability of a company's core operations. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes.

Highlights and Quick Summary

  • EBIT Margin for the quarter ending June 30, 2022 was -8.53% (a -11.97% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Margin decreased by -359.27%
  • Annual EBIT Margin for 2021 was -24.2% (a 99.01% increase from previous year)
  • Annual EBIT Margin for 2020 was -12.16% (a -120.11% decrease from previous year)
  • Annual EBIT Margin for 2019 was 60.46% (a 46.71% increase from previous year)
  • Twelve month EBIT Margin ending June 30, 2022 was -9.73% (a 566.44% increase compared to previous quarter)
  • Twelve month trailing EBIT Margin increased by 126.28% year-over-year
Trailing EBIT Margin for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-9.73% -1.46% 1.77% -4.3%
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Margin of Anika Therapeutics Inc.

Most recent EBIT Marginof ANIK including historical data for past 10 years.

Interactive Chart of EBIT Margin of Anika Therapeutics Inc.

Anika Therapeutics Inc. EBIT Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -8.53% -9.69% – – –
2021 -25.47% 3.29% 24.07% 3.67% -24.2%
2020 -54.92% -25.01% -31.08% 20.04% -12.16%
2019 16.13% 40.57% 39.17% 22.17% 60.46%
2018 36.21% 32.0% 36.81% -36.83% 41.21%
2017 33.1% 37.78% 52.97% 34.23% 80.64%
2016 44.35% 53.08% 50.67% 48.06% 48.95%
2015 55.24% 55.47% 54.27% 35.46% 51.76%
2014 51.98% 46.64% 57.86% 70.19% 58.19%
2013 49.08% 43.74% 45.12% 32.87% 43.43%
2012 34.47% 18.47% 31.26% 21.33% 27.63%
2011 26.65% 26.1% – – 21.56%

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices
© stockrow.com